Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

2004
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2013 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Biomarkers in pulmonary hypertension: what do we know?
Foris V, Kovacs G, Tscherner M, Olschewski A, Olschewski H. Foris V, et al. Chest. 2013 Jul;144(1):274-283. doi: 10.1378/chest.12-1246. Chest. 2013. PMID: 23880678 Review.
In this review, markers related to heart failure, inflammation, hemostasis, remodeling, and endothelial cell-smooth muscle cell interaction are discussed, and their limitations are emphasized. Anemia, hypocarbia, elevated uric acid, and C-reactive protein levels are …
In this review, markers related to heart failure, inflammation, hemostasis, remodeling, and endothelial cell-smooth muscle cell interaction …
Pathophysiology of vascular calcification in chronic kidney disease.
Moe SM, Chen NX. Moe SM, et al. Circ Res. 2004 Sep 17;95(6):560-7. doi: 10.1161/01.RES.0000141775.67189.98. Circ Res. 2004. PMID: 15375022 Review.
However, a lack of inhibitors of calcification may also be important. Dialysis patients with low levels of serum fetuin-A, a circulating inhibitor of mineralization, have increased coronary artery calcification and fetuin-A can inhibit mineralization of vascular smo …
However, a lack of inhibitors of calcification may also be important. Dialysis patients with low levels of serum fetuin-A, a circu